Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | GRM5 | P41594 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29824353 | 1.00 | MAPK1 (0.52) | MAPK1TDP1CYP3A4TRPA1TSHR | |
| SCHEMBL6418213 | 0.86 | CYP3A4 (0.46) | MAPK1TDP1CYP3A4TRPA1TSHR | |
| SCHEMBL7158060 | 0.83 | CYP3A4 (0.60) | MAPK1TDP1CYP3A4TRPA1TSHR | |
| SCHEMBL9630076 | 0.83 | CYP3A4 (0.55) | MAPK1TDP1CYP3A4TRPA1TSHR | |
| SCHEMBL29454784 | 0.81 | MAPK1 (0.68) | MAPK1TDP1CYP3A4TRPA1TSHR | |
| SCHEMBL418944 | 0.81 | CYP3A4 (0.58) | MAPK1TDP1CYP3A4TRPA1TSHR | |
| SCHEMBL15620862 | 0.81 | MAPK1 (0.47) | MAPK1TDP1CYP3A4TRPA1TSHR | |
| SCHEMBL9859656 | 0.81 | MAPK1 (0.47) | MAPK1TDP1CYP3A4TRPA1TSHR | |
| SCHEMBL3831454 | 0.81 | MAPK1 (0.68) | MAPK1TDP1CYP3A4TRPA1TSHR | |
| SCHEMBL29648923 | 0.81 | CYP3A4 (0.58) | MAPK1TDP1CYP3A4TRPA1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 522 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119912405-A | Fluothidiazuron derivative and preparation method thereof | 河南省科学院高新技术研究中心 | 2025-05-02 | — | — | CN | claimed |
| CN-118638407-A | Modified nylon material for laser welding and preparation method thereof | 瑞安市君诚塑胶制造有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-115746696-B | Polyimide paint for high-heat-resistance enameled wire and high-heat-resistance enameled wire | 浙江中科玖源新材料有限公司 | 2023-12-19 | — | — | CN | claimed |
| CN-115746696-A | Polyimide paint for high-heat-resistance enameled wire and high-heat-resistance enameled wire | 浙江中科玖源新材料有限公司 | 2023-03-07 | — | — | CN | claimed |
| EP-1377589-B1 | OXAZOLYL-PYRAZOLE DERIVATIVES AS KINASE INHIBITORS | PHARMACIA ITALIA SPA (IT) | 2005-09-07 | — | — | EP | claimed |
| CN-122025811-A | High-temperature electrolyte additive, electrolyte and lithium ion battery | 西安热工研究院有限公司 | 2026-05-12 | — | — | CN | disclosed |
| EP-4713378-A1 | ESTERIFIED ETHANOLAMINES FOR PREPARING ISOCYANURATE POLYMERS | Covestro Deutschland AG (DE) | 2026-03-25 | — | — | EP | disclosed |
| US-12479850-B2 | Compound having Axl and c-Met kinase inhibitory activity, preparation thereof and application thereof | SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES (CN) | 2025-11-25 | — | — | US | disclosed |
| CN-119912405-A | Fluothidiazuron derivative and preparation method thereof | 河南省科学院高新技术研究中心 | 2025-05-02 | — | — | CN | disclosed |
| CN-119908364-A | Cotton defoliant containing fluhiuron derivative and application thereof | 河南省科学院高新技术研究中心 | 2025-05-02 | — | — | CN | disclosed |
| US-20250074901-A1 | NOVEL HETEROARYL COMPOUNDS | ANGELINI PHARMA S.P.A. (IT) | 2025-03-06 | — | — | US | disclosed |
| EP-3774961-B1 | ADDUCTS OF AMINE CATALYSTS FOR PRODUCING ISOCYANURATE POLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2025-01-15 | — | — | EP | disclosed |
| US-4996208-A | Pesticidal thiazolopyrimidine derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 1991-02-26 | — | — | US | disclosed |
| US-4983751-A | Chemical intermediates | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1991-01-08 | — | — | US | disclosed |
| EP-0340243-A1 | CC-1065 ANALOGS. | UPJOHN CO (US) | 1989-11-08 | — | — | EP | disclosed |
| EP-0324175-A1 | Difluorphenyl urea derivatives | BAYER AG (DE) | 1989-07-19 | — | — | EP | disclosed |
| US-4818272-A | NONPHYTOTOXICITY FOR CROPS HELICAL STREAMS | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1989-04-04 | — | — | US | disclosed |
| WO-1988004659-A2 | NOVEL CC-1065 ANALOGS | THE UPJOHN COMPANY (US) | 1988-06-30 | — | — | WO | disclosed |
| EP-0241559-A1 | OXAZOLIDINEDIONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND HERBICIDES CONTAINING THE SAME | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 1987-10-21 | — | — | EP | disclosed |
| US-4131751-A | PHENYLENE, PLANT GROWTH REGULATORS | BASF AKTIENGESELLSCHAFT (DE) | 1978-12-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250074901-A1 | NOVEL HETEROARYL COMPOUNDS | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CYP3A43, F12 | MAPK1 2595/4885TDP1 2961/4885CYP3A4 18/4885 |
| US-12479850-B2 | Compound having Axl and c-Met kinase inhibitory activity, preparation thereof and application thereof | MET, MERTK, AXL | MAPK1 121/4885TDP1 4589/4885CYP3A4 3564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.